IP Verse

Stabilized Modified Release Vitamin D Formulation And Method Of Administring Same - EP2968172

EP2968172

EIRGEN PHARMA
Application Number
EP14717038A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Jun 19, 2020
Grant Date
Oct 7, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3650016B1
EP3332773B8

Bibliography

The patent EP2968172B8 was granted to Eirgen Pharma on Oct 7, 2020 following the initial filing on Mar 14, 2014 under the application number EP14717038A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DSM NUTRITIONAL PRODUCTSApr 21, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents